Dog /

Breed profile · FDA CVM July 2026 extract

Terrier - Fox Wire adverse-event record

Adverse-event filings for Terrier - Fox Wire (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#150 of 510
by report volume (all breeds)
434
FDA CVM reports on file
5.1%
death-coded share of reports
#128 of 275
by death-coded share (≥50 reports)

How the 434 reports break down

By recorded gender -- every report on file for Terrier - Fox Wire, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 38 28.5 19 9.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Terrier - Fox Wire drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Terrier - Fox Wire ranks #150 of 510 by total reports (434) and #127 of 275 by death-coded share (5.1%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#150
This breed, reports of 510
#127
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Terrier - Fox Wire has 434 reports now versus 431 in that prior snapshot: 3 more (0.7%).

Report change
+3
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Terrier - Fox Wire changes

Total Reports

434

Above-median volume

Deaths Reported

22

of 434 reports

Death-coded share of reports

5.1%

Above-median death-coded share

Avg Age at Report

6.5 yr

9.9 kg avg weight

Breed Safety Scorecard

C+ (60/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate D
5.1%

Share of reports coded as a fatality

Euthanasia rate D
2.3%

Share of reports resulting in euthanasia

Full recovery rate B
34.3%

Share of reports coded "Recovered/Normal"

5-year trend A
-47%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Terrier - Fox Wire death-coded reports 5.1%
Cross-breed median

5.1% of 434 terrier - fox wire reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Terrier - Fox Wire's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

5% 53rd percentile Higher share than 53% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Terrier - Fox Wire 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 9.9 kg (21.8 lbs)

Top Reported Reactions

Vomiting 97
Lethargy (see also Central nervous system depression in 'Neurological') 51
Diarrhoea 30
Emesis 27
Lack of efficacy (endoparasite) - heartworm 27
Lack of efficacy (ectoparasite) - flea 23
Lack of efficacy - NOS 20
Other abnormal test result NOS 18

Most Referenced Drugs

Milbemycin Oxime + Spinosad 93
Ivermectin + Pyrantel As Pamoate Salt 36
Afoxolaner 35
Oclacitinib Maleate 31
Milbemycin Oxime + Praziquantel 24
Pyrantel Pamoate;Sarolaner 22
Trilostane 20
Spinosad 16

Outcome Breakdown

Recovered/Normal
149 (34.3%)
Outcome Unknown
142 (32.7%)
Ongoing
110 (25.3%)
Died
12 (2.8%)
Recovered with Sequela
11 (2.5%)
Euthanized
10 (2.3%)

Gender Distribution

Male 215 (49.5%)
Female 212 (48.8%)
Unknown 7 (1.6%)

Reports by Year

Year Reports Trend
2011 8
2012 35
2013 29
2014 29
2015 25
2016 45
2017 35
2018 35
2019 23
2020 31
2021 38
2022 20
2023 35
2024 23
2025 20
2026 3

Terrier - Fox Wire: high-volume FDA adverse-event cohort

Signature read: 434 reports place Terrier - Fox Wire in the upper third of breed filing volume (#150 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Terrier - Fox Wire sits at #150 of 510 by report volume among all breeds and #123 of 298 among dog breeds, with 434 reports and 22 (5.1%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #128 of 275. Mean age at report: 6.5 years, average weight 9.9 kg (21.8 lbs).

Top reported signs: Vomiting (97), Lethargy (see also Central nervous system depression in 'Neurological') (51), Diarrhoea (30). Most-referenced drug: Milbemycin Oxime + Spinosad (93 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (36) and Afoxolaner (35).

Outcome coding on 434 status-recorded reports is dominated by Recovered/Normal (34.3%). Annual submissions ranged 3-2,026 across 16 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Terrier - Fox Wire drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (5.1% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (9.9 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Terrier - Fox Wire?
There are 434 adverse event reports involving Terrier - Fox Wire in the FDA database, of which 22 were death-coded (5.1% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Terrier - Fox Wire ranks #150 of 510 by report volume among all breeds PlainBreed indexes (#123 of 298 among dog breeds).
Where does Terrier - Fox Wire sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Terrier - Fox Wire is #150 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #123 of 298. Among breeds with at least 50 reports, its death-coded share ranks #128 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Terrier - Fox Wire?
The most commonly reported adverse reactions for Terrier - Fox Wire are Vomiting (97 reports), Lethargy (see also Central nervous system depression in 'Neurological') (51 reports), Diarrhoea (30 reports), Emesis (27 reports), Lack of efficacy (endoparasite) - heartworm (27 reports).
What drugs are most frequently associated with Terrier - Fox Wire adverse events?
The drugs most frequently referenced in Terrier - Fox Wire adverse event reports are Milbemycin Oxime + Spinosad (93 reports), Ivermectin + Pyrantel As Pamoate Salt (36 reports), Afoxolaner (35 reports), Oclacitinib Maleate (31 reports), Milbemycin Oxime + Praziquantel (24 reports).
What is the average age of Terrier - Fox Wire in adverse event reports?
The average age of Terrier - Fox Wire at the time of adverse event reports is 6.5 years, with an average weight of 9.9 kg (21.8 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Terrier - Fox Wire (Dog), extract as of July 2026 extract. 434 reports · 22 death-coded (5.1% of reports, not a mortality rate) · #150 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →